PURPOSE: Reported employment rates for patients with psychosis are low, but vary partly depending on illness phase. Illness-related factors such as neurocognition and negative symptoms are associated with occupational functioning, while external factors may also act as barriers for employment. The current study investigated the relationship between neurocognition, symptoms and employment using a threefold division of employment status: employed, receiving temporary benefits and receiving disability benefits. The latter group was divided into two based on level of social functioning. METHODS: A total of 155 patients with broad DSM-IV schizophrenia spectrum disorder were assessed with clinical, neurocognitive and social and occupational functioning measures. Group differences were analyzed with ANOVAs and hierarchical regression analysis. RESULTS: Thirteen percent were employed, 52 % received temporary benefits and 35 % received disability benefits. There were no differences in symptom level and neurocognitive functioning between groups. Among patients on disability benefits, the subgroup with higher social functioning had fewer negative and general symptoms and a trend for better neurocognition compared with those with lower social functioning, thus being more similar to employed patients. Negative symptoms and executive functioning explained 26 % of the variance in social functioning for patients receiving disability benefits. CONCLUSIONS: The association between neurocognition and employment may not be as strong as previously assumed, due to external factors that may influence this relationship. Patients on disability benefits rated high on social functioning showed similarities with employed patients. This could imply that these patients have some work capacity. This issue needs further investigation.
PURPOSE: Reported employment rates for patients with psychosis are low, but vary partly depending on illness phase. Illness-related factors such as neurocognition and negative symptoms are associated with occupational functioning, while external factors may also act as barriers for employment. The current study investigated the relationship between neurocognition, symptoms and employment using a threefold division of employment status: employed, receiving temporary benefits and receiving disability benefits. The latter group was divided into two based on level of social functioning. METHODS: A total of 155 patients with broad DSM-IV schizophrenia spectrum disorder were assessed with clinical, neurocognitive and social and occupational functioning measures. Group differences were analyzed with ANOVAs and hierarchical regression analysis. RESULTS: Thirteen percent were employed, 52 % received temporary benefits and 35 % received disability benefits. There were no differences in symptom level and neurocognitive functioning between groups. Among patients on disability benefits, the subgroup with higher social functioning had fewer negative and general symptoms and a trend for better neurocognition compared with those with lower social functioning, thus being more similar to employed patients. Negative symptoms and executive functioning explained 26 % of the variance in social functioning for patients receiving disability benefits. CONCLUSIONS: The association between neurocognition and employment may not be as strong as previously assumed, due to external factors that may influence this relationship. Patients on disability benefits rated high on social functioning showed similarities with employed patients. This could imply that these patients have some work capacity. This issue needs further investigation.
Authors: Hector W H Tsang; Ada Y Leung; Raymond C K Chung; Morris Bell; Wai-Ming Cheung Journal: Aust N Z J Psychiatry Date: 2010-06 Impact factor: 5.744
Authors: Tone Hellvin; Kjetil Sundet; Anja Vaskinn; Carmen Simonsen; Torill Ueland; Ole A Andreassen; Ingrid Melle Journal: Scand J Psychol Date: 2010-12
Authors: Marte Tandberg; Torill Ueland; Kjetil Sundet; Ulrik Haahr; Inge Joa; Jan Olav Johannessen; Tor Ketil Larsen; Stein Opjordsmoen; Bjørn Rishovd Rund; Jan Ivar Røssberg; Erik Simonsen; Per Vaglum; Ingrid Melle; Svein Friis; Thomas McGlashan Journal: Psychiatry Res Date: 2011-05-14 Impact factor: 3.222
Authors: Richard J Drake; Graham Dunn; Nick Tarrier; Richard P Bentall; Gillian Haddock; Shôn W Lewis Journal: J Clin Psychiatry Date: 2007-01 Impact factor: 4.384
Authors: Jamie Joseph; William S Kremen; Stephen J Glatt; Carol E Franz; Sharon D Chandler; Xiaohua Liu; Barbara K Johnson; Ming T Tsuang; Elizabeth W Twamley Journal: J Psychiatr Res Date: 2015-04-11 Impact factor: 4.791